Study Links Autism to Higher Risk of Parkinson's Disease
New study reveals link between autism spectrum disorder and Parkinson's disease, highlighting shared biological mechanisms. Clene Inc. (NASDAQ: CLNN) could benefit from this research. Learn more about the study findings and implications here.
This news sheds light on a potential connection between ASD and PD, impacting individuals with autism and raising awareness about the risks of developing Parkinson's disease. Companies like Clene Inc. may use this research to bring new treatments to market, potentially improving the lives of those affected by these conditions.
